Product
Effective from January 2011, the Company started marketing of Fentanyl Transdermal Patches, continuing its efforts to bring more Product under pain management, in September 2011, the Company launched two more Product for the Indian market, viz. Diclofenac diethylamine Transdermal Patches for the relief of pain and inflammation and Ketoprofen Plaster for the relief of musculoskeletal pain and inflammation.
| Therapeutic Category | API | Strength | Indication | Duration of Action |
|---|---|---|---|---|
| Pain management | Fentanyl | 12.5, 25, 50, 75 & 100 mcg/hr | Cancer pain | 3 days |
| Buprenorphine | 5, 10 & 20 mcg/hr | Severe chronic pain | 7 days | |
| Diclofenac diethylaminE | 100 mg | Pain and inflammation | 1 day | |
| Lidocaine | 5% | Post-herpetic neuralgia | 1 day | |
| CNS | Rivastigmine | 9, 18, 27 & 36 mg | Alzheimer’s & Parkinson’s associated dementia | 1 day |
| Respiratory | Tulobuterol | 0.5, 1.0 & 2.0 mg | COPD and Asthma | 1 day |
| NRT | Nicotine | 7, 14, 21 mg | Smoking Cessation | 1 day |
